Clinical observation of Baduanjin training with wearable device on the elderly patients with heart failure
Objective To observe the clinical effect of Baduanjin training with wearable device on the elderly patients with heart failure.Methods A total of 60 elderly patients with chronic heart failure were selected from the Department of Cardiology of Long-hua Hospital from June 2020 to December 2021.The patients were randomly divided into control group and intervention group.They were given routine rehabilitation(standardized drug therapy and Baduanjin exercises)or routine rehabilitation and wearable device quality control for 3 months,before and after treatment,respectively.Cardiopulmonary exercise test was performed on the patients,and peak oxygen uptake of cardiopulmonary function index(VO2peak)and anaerobic threshold oxygen uptake(VO2@AT)were detected and recorded.At the same time,EF and NT-proBNP before and after treatment were detected,and the quality of life of patients was scored using the Minnesota Quality Rating Scale(C-MLHF)based on Chinese culture improvement.Results The maximum oxygen uptake(VO2peak),anaerobic threshold(VO2@AT),left ventricular ejection fraction(LVEF),amino terminal brain natriuretic pep-tide precursor(NT-proBNP)and Minnesota quality score(C-MLHF)in treatment group were superior to those in control group,with statistical significance(P<0.05).The comparison of peak oxygen intake VO2peak,anaerobic threshold VO2@AT,NT-proBNP and C-MLHF in the control group before and after 3 months of treatment showed that the results after treatment were better than those be-fore and after treatment,with statistical significance(P<0.05),while there was no significant difference in LVEF before and after treatment(P>0.05).The comparison of peak oxygen intake VO2peak,anaerobic threshold VO2@AT,NT-proBNP and C-MLHF be-fore and after 3 months of treatment in the treatment group showed that the results after treatment were better than those before and after treatment,with statistical significance(P<0.05),while there was no significant difference in LVEF before and after treatment(P>0.05).Conclusion Under the wearable device,the setting and monitoring of the target heart rate range based on the anaero-bic threshold heart rate can effectively control the quality of exercise intensity.Effectively improve the maximal oxygen uptake(VO2peak),anaerobic threshold(VO2@AT),left ventricular ejection fraction(LVEF),amino terminal brain natriuretic peptide pre-cursor(NT-proBNP),Minnesota quality score(C-MLHF)in elderly patients with heart failure.
万方数据
维普
